» Articles » PMID: 22684913

Lipid Transfer to HDL is Higher in Marathon Runners Than in Sedentary Subjects, but is Acutely Inhibited During the Run

Overview
Journal Lipids
Specialty Biochemistry
Date 2012 Jun 12
PMID 22684913
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Although exercise increases HDL-cholesterol, exercise-induced changes in HDL metabolism have been little explored. Lipid transfer to HDL is essential for HDL's role in reverse cholesterol transport. We investigated the effects of acute exhaustive exercise on lipid transfer to HDL. We compared plasma lipid, apolipoprotein and cytokine levels and in vitro transfer of four lipids from a radioactively labeled lipid donor nanoemulsion to HDL in sedentary individuals (n = 28) and in marathon runners (n = 14) at baseline, immediately after and 72 h after a marathon. While HDL-cholesterol concentrations and apo A1 levels were higher in marathon runners, LDL-cholesterol, apo B and triacylglycerol levels were similar in both groups. Transfers of non-esterified cholesterol [6.8 (5.7-7.2) vs. 5.2 (4.5-6), p = 0.001], phospholipids [21.7 (20.4-22.2) vs. 8.2 (7.7-8.9), p = 0.0001] and triacylglycerol [3.7 (3.1-4) vs. 1.3 (0.8-1.7), p = 0.0001] were higher in marathon runners, but esterified-cholesterol transfer was similar. Immediately after the marathon, LDL- and HDL-cholesterol concentrations and apo A1 levels were unchanged, but apo B and triacylglycerol levels increased. Lipid transfer of non-esterified cholesterol [6.8 (5.7-7.2) vs. 5.8 (4.9-6.6), p = 0.0001], phospholipids [21.7 (20.4-22.2) vs. 19.1 (18.6-19.3), p = 0.0001], esterified-cholesterol [3.2 (2.2-3.8) vs. 2.3 (2-2.9), p = 0.02] and triacylglycerol [3.7 (3.1-4) vs. 2.6 (2.1-2.8), p = 0.0001] to HDL were all reduced immediately after the marathon but returned to baseline 72 h later. Running a marathon increased IL-6 and TNF-α levels, but after 72 h these values returned to baseline. Lipid transfer, except esterified-cholesterol transfer, was higher in marathon runners than in sedentary individuals, but the marathon itself acutely inhibited lipid transfer. In light of these novel observations, further study is required to clarify how these metabolic changes can influence HDL composition and anti-atherogenic function.

Citing Articles

ANGPTL4, IL-6 and TNF-α as regulators of lipid metabolism during a marathon run.

Gorecka M, Krzeminski K, Mikulski T, Ziemba A Sci Rep. 2022; 12(1):19940.

PMID: 36402848 PMC: 9675781. DOI: 10.1038/s41598-022-17439-x.


Exercise training-induced changes in immunometabolic markers in youth badminton athletes.

Rossi F, Maldonado A, Cholewa J, Ribeiro S, DE Araujo Barros C, Figueiredo C Sci Rep. 2022; 12(1):15539.

PMID: 36109571 PMC: 9477844. DOI: 10.1038/s41598-022-19591-w.


Changes in Cytokines Concentration Following Long-Distance Running: A Systematic Review and Meta-Analysis.

de Jesus Alves M, Dos Santos Silva D, Moura Pereira E, Dutra Pereira D, de Sousa Fernandes M, Santos D Front Physiol. 2022; 13:838069.

PMID: 35250639 PMC: 8893166. DOI: 10.3389/fphys.2022.838069.


Effect of mountain ultra-marathon running on plasma angiopoietin-like protein 4 and lipid profile in healthy trained men.

Gorecka M, Krzeminski K, Buraczewska M, Kozacz A, Dabrowski J, Ziemba A Eur J Appl Physiol. 2019; 120(1):117-125.

PMID: 31707478 PMC: 6969869. DOI: 10.1007/s00421-019-04256-w.


Reverse Cholesterol Transport: Molecular Mechanisms and the Non-medical Approach to Enhance HDL Cholesterol.

Marques L, Diniz T, Antunes B, Rossi F, Caperuto E, Lira F Front Physiol. 2018; 9:526.

PMID: 29867567 PMC: 5962737. DOI: 10.3389/fphys.2018.00526.


References
1.
Rubin D, Hackney A . Inflammatory cytokines and metabolic risk factors during growth and maturation: influence of physical activity. Med Sport Sci. 2010; 55:43-55. DOI: 10.1159/000321971. View

2.
Wu H, Chen K, Shee B, Chang H, Huang Y, Yang R . Effects of 24 h ultra-marathon on biochemical and hematological parameters. World J Gastroenterol. 2004; 10(18):2711-4. PMC: 4572198. DOI: 10.3748/wjg.v10.i18.2711. View

3.
Khera A, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke M, Jafri K . Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med. 2011; 364(2):127-35. PMC: 3030449. DOI: 10.1056/NEJMoa1001689. View

4.
Ginsburg G, Small D, Atkinson D . Microemulsions of phospholipids and cholesterol esters. Protein-free models of low density lipoprotein. J Biol Chem. 1982; 257(14):8216-27. View

5.
Nomura K, Noguchi Y, Yoshikawa T, Kondo J . Plasma interleukin-6 is not a mediator of changes in lipoprotein lipase activity in cancer patients. Hepatogastroenterology. 1997; 44(17):1519-26. View